Implanet SA (IMPZY)
0.08
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Implanet Total Liabilities (Quarterly): 11.95M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 11.95M |
June 30, 2023 | 11.21M |
June 30, 2023 | 11.21M |
December 31, 2022 | 11.73M |
June 30, 2022 | 14.12M |
June 30, 2022 | 14.12M |
December 31, 2021 | 15.74M |
June 30, 2021 | 19.04M |
June 30, 2021 | 19.04M |
December 31, 2020 | 9.446M |
June 30, 2020 | 8.170M |
June 30, 2020 | 8.170M |
December 31, 2019 | 9.201M |
June 30, 2019 | 9.319M |
June 30, 2019 | 9.319M |
December 31, 2018 | 7.375M |
Date | Value |
---|---|
June 30, 2018 | 7.712M |
June 30, 2018 | 7.712M |
December 31, 2017 | 7.528M |
June 30, 2017 | 8.848M |
June 30, 2017 | 8.848M |
December 31, 2016 | 7.187M |
June 30, 2016 | 8.947M |
June 30, 2016 | 8.947M |
December 31, 2015 | 7.177M |
June 30, 2015 | 8.958M |
June 30, 2015 | 8.958M |
December 31, 2014 | 8.926M |
June 30, 2014 | 11.34M |
June 30, 2014 | 11.34M |
December 31, 2013 | 13.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.170M
Minimum
Jun 2020
19.04M
Maximum
Jun 2021
12.12M
Average
11.21M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
DBV Technologies SA | 34.24M |
Cellectis SA | 249.58M |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | 117.09M |
Innate Pharma SA | 146.24M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 11.76M |
Shareholders Equity (Quarterly) | -0.1923M |
Debt to Equity Ratio | -31.75 |
Current Ratio | 0.7148 |
Net Debt Paydown Yield | 0.79% |